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Abstract
Surgical wound infection remains a significant problem following an operation, although surveillance
for such infections remains a challenge exacerbated by early discharge and outpatient surgery. The
riskof such infections isdetermined by technical problems with the operation, particularly bleeding,
the amount of devitalized tissue created, and the need for drains within the wound, as well as such
metabolic factors as obesity and diabetes. Perioperative antibiotic prophylaxis can decrease the
incidence of such infections further, but a technically perfect operation is even more important.
Text
Modern surgery can be said to have its roots in the 19th
century, when reconstructive, tissue-preserving operations
began to replace amputations. These became possible
after Lister introduced the aseptic treatment of wounds,
and when it was recognized that successful surgery was
predicated on the technical skill of the surgical team, the
limitation of the number of microorganisms introduced
into the surgical wound, and the presence of systemic and
local factors that enhance the ability of the patient to limit
microbial replication and invasion. With the advent of
systemic, perioperative antimicrobials, natural host
defenses were reinforced, and the ability to perform more
complicated operations was greatly enhanced. Early on in
the antimicrobial era, it was recognized that the skill of
the surgeon and his ability to prevent the formation of
fluid collections, limit the extent of residual devitalized
tissue, and achieve the prompt removal of drains and
devices that traverse and potentially injure the primary
mucocutaneous barrier were even more important than
the choice of antimicrobial prophylaxis [1-3].
That is not to say, however, that surgical site infections
(SSI) were eliminated by these interventions; indeed, the
identification and surveillance of SSIs has been made
more challenging by shorter hospital stays and the
increasing use of outpatient surgery. The current study by
Petherick and colleagues [4] emphasizes the continuing
challenges of monitoring postoperative patients for SSI,
evaluating new management approaches to the preven-
tion and treatment of SSIs, and the need for a workable
classification system that will facilitate the collection of
data in a geographically and clinically diverse population.
At present, the system devised by the Centers for Disease
Control (CDC) appears to be most workable. Thus, SSIs
are divided into the following categories upon assessment
at 30 days post surgery: incisional SSIs – these can be super-
ficial and involve only the skin and subcutaneous tissue of
the incision, with physical findings of inflammation; deep
incisional SSIs – these are also defined at 30 days post sur-
gery or at one year if an implant is involved, and involve
infection present in the deep soft tissues of the incision;
Published: 27 November 2006
BMC Infectious Diseases 2006, 6:171 doi:10.1186/1471-2334-6-171
Received: 07 November 2006
Accepted: 27 November 2006
This article is available from: http://www.biomedcentral.com/1471-2334/6/171
© 2006 Rubin; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Infectious Diseases 2006, 6:171 http://www.biomedcentral.com/1471-2334/6/171
Page 2 of 2
(page number not for citation purposes)
and finally, organ/space SSIs, which involve any part of the
anatomy other than the incision itself [5,6].
With this evaluation system in place, one can then pro-
ceed to a wound classification system in order to define
risk of wound infection. This effort divides surgical
patients into clean, clean-contaminated, contaminated, and
infected or dirty as they enter the operating room. Within
these categories, the following issues can be assessed:
microbe-related risk factors, with Staphylococcus aureus
and  Streptococcus pyogenes being particularly virulent;
host-related risk factors, with morbid obesity, an index
of disease severity, old age, protein-calorie malnutrition,
and, probably, diabetes, cancer, and systemic infection;
and operation-related risk factors, including prolonged
hospital stay before surgery, duration of the operation, tis-
sue trauma, poor hemostasis, and foreign material in the
wound, with these last greatly increasing the risk of seri-
ous infection despite a relatively small bacterial inocu-
lum. The performance of an intra-abominal procedure,
operation time >2 hours, a contaminated or dirty-infected
operation, and concomitant illness of significance were
other important factors [3].
How do we translate surveillance information into a
patient management paradigm? The first concern is the
surgical wound – the presence of devitalized tissue, the
need for foreign body placement, and establishment of
hemostasis are of primary importance. In particular,
blood in the wound becomes a major problem with
hemostasis, and provides large amounts of iron, an essen-
tial growth factor for the organisms of concern. Correction
of these abnormalities is essential, both for the treatment
of established infections and for the prevention of further
infection. In recent years, the person-to-person transmis-
sion of drug-resistant bacteria and yeast on the hands of
medical personnel has become an important problem.
The impact of such organisms as methicillin-resistant S.
aureus, vancomycin-resistant enterococci, and resistant
gram-negative organisms on hospitalized patients in gen-
eral, but on causation of wound infection in particular,
cannot be overemphasized [3].
The probability of wound infection is determined largely
by the interaction of the microbial burden, local wound
conditions, and the patient's systemic host defenses. The
conditions of antimicrobial therapy, both prophylacti-
cally and therapeutically, can only be defined when these
other factors are under control [3].
There is little question that SSIs contribute significantly to
the cost, the morbidity, and the possible long-term conse-
quences of a surgical procedure. Petherick et al [4] have
made a compelling case that ongoing outpatient surveil-
lance could play a significant role in early recognition of a
problem, as well as providing the best opportunity for
intervention in the management of SSIs. Two significant
hurdles must be overcome if this is to be successful: the
adoption of a surveillance system acceptable to all, includ-
ing not only the criteria for assessing wounds, but also the
timing of such encounters; and the second hurdle is cost.
However, I am persuaded that the prevention of signifi-
cant wound infection will be economically viable pro-
vided that the logistic support is put into place. Petherick
and her colleagues have done us a great service by not only
calling our attention to a solvable problem, but also
because of the importance of these observations [3,4].
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